SV2018005657A - "nuevos derivados de imidazo[4,5-b]piridina, un proceso para su preparacion y composiciones farmaceuticas que los contienen" - Google Patents
"nuevos derivados de imidazo[4,5-b]piridina, un proceso para su preparacion y composiciones farmaceuticas que los contienen"Info
- Publication number
- SV2018005657A SV2018005657A SV2018005657A SV2018005657A SV2018005657A SV 2018005657 A SV2018005657 A SV 2018005657A SV 2018005657 A SV2018005657 A SV 2018005657A SV 2018005657 A SV2018005657 A SV 2018005657A SV 2018005657 A SV2018005657 A SV 2018005657A
- Authority
- SV
- El Salvador
- Prior art keywords
- piridina
- imidazo
- contain
- preparation
- pharmaceutical compositions
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
COMPUESTOS DE FÓRMULA (I): (VER FORMULA) EN LA QUE R1, R2, R3, R4, Y R5 SON COMO SE DEFINEN EN LA DESCRIPCIÓN
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1559252A FR3041639B1 (fr) | 2015-09-30 | 2015-09-30 | NOUVEAUX DERIVES D'IMIDAZO[4,5-b]PYRIDINE, PROCEDE POUR LES PREPARER ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2018005657A true SV2018005657A (es) | 2018-07-31 |
Family
ID=54979755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2018005657A SV2018005657A (es) | 2015-09-30 | 2018-03-22 | "nuevos derivados de imidazo[4,5-b]piridina, un proceso para su preparacion y composiciones farmaceuticas que los contienen" |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20180273528A1 (es) |
| EP (1) | EP3356363A1 (es) |
| JP (1) | JP2018535931A (es) |
| KR (1) | KR20180054858A (es) |
| CN (1) | CN108137581A (es) |
| AU (1) | AU2016333505A1 (es) |
| BR (1) | BR112018006157A2 (es) |
| CA (1) | CA2999935A1 (es) |
| CL (1) | CL2018000783A1 (es) |
| CO (1) | CO2018003473A2 (es) |
| CR (1) | CR20180181A (es) |
| CU (1) | CU20180028A7 (es) |
| DO (1) | DOP2018000083A (es) |
| EA (1) | EA201890821A1 (es) |
| EC (1) | ECSP18023253A (es) |
| FR (1) | FR3041639B1 (es) |
| HK (1) | HK1255804A1 (es) |
| IL (1) | IL258341A (es) |
| MA (1) | MA43020A (es) |
| MX (1) | MX2018003860A (es) |
| NI (1) | NI201800043A (es) |
| PE (1) | PE20181331A1 (es) |
| PH (1) | PH12018500650A1 (es) |
| SV (1) | SV2018005657A (es) |
| TN (1) | TN2018000090A1 (es) |
| WO (1) | WO2017055530A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12528810B2 (en) | 2018-03-01 | 2026-01-20 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of DYRK/CLK and uses thereof |
| CN108822103A (zh) * | 2018-07-28 | 2018-11-16 | 刘凤娟 | 一种咪唑并[4,5-b]吡啶化合物及其制备方法和应用 |
| CN113164476A (zh) * | 2018-09-28 | 2021-07-23 | 代表亚利桑那大学的亚利桑那校董会 | Dyrk1/clk的小分子抑制剂及其用途 |
| AU2019372046B2 (en) | 2018-10-31 | 2022-05-26 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds as HPK1 inhibitors |
| EP3873608A1 (en) | 2018-10-31 | 2021-09-08 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity |
| WO2020237025A1 (en) | 2019-05-23 | 2020-11-26 | Gilead Sciences, Inc. | Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors |
| CN114786673A (zh) * | 2019-09-11 | 2022-07-22 | 普莱鲁德疗法有限公司 | Cdk抑制剂及其作为药物的用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105189481A (zh) * | 2013-03-13 | 2015-12-23 | 艾伯维公司 | 吡啶cdk9激酶抑制剂 |
-
2015
- 2015-09-30 FR FR1559252A patent/FR3041639B1/fr not_active Expired - Fee Related
-
2016
- 2016-09-30 WO PCT/EP2016/073395 patent/WO2017055530A1/en not_active Ceased
- 2016-09-30 KR KR1020187012175A patent/KR20180054858A/ko not_active Withdrawn
- 2016-09-30 CA CA2999935A patent/CA2999935A1/en not_active Abandoned
- 2016-09-30 AU AU2016333505A patent/AU2016333505A1/en not_active Abandoned
- 2016-09-30 CR CR20180181A patent/CR20180181A/es unknown
- 2016-09-30 CN CN201680058054.0A patent/CN108137581A/zh not_active Withdrawn
- 2016-09-30 MA MA043020A patent/MA43020A/fr unknown
- 2016-09-30 HK HK18114643.2A patent/HK1255804A1/zh unknown
- 2016-09-30 TN TNP/2018/000090A patent/TN2018000090A1/en unknown
- 2016-09-30 JP JP2018516194A patent/JP2018535931A/ja active Pending
- 2016-09-30 CU CUP2018000028A patent/CU20180028A7/es unknown
- 2016-09-30 EA EA201890821A patent/EA201890821A1/ru unknown
- 2016-09-30 PE PE2018000443A patent/PE20181331A1/es unknown
- 2016-09-30 US US15/763,248 patent/US20180273528A1/en not_active Abandoned
- 2016-09-30 EP EP16774682.5A patent/EP3356363A1/en not_active Withdrawn
- 2016-09-30 MX MX2018003860A patent/MX2018003860A/es unknown
- 2016-09-30 BR BR112018006157A patent/BR112018006157A2/pt not_active Application Discontinuation
-
2018
- 2018-03-22 SV SV2018005657A patent/SV2018005657A/es unknown
- 2018-03-23 PH PH12018500650A patent/PH12018500650A1/en unknown
- 2018-03-23 NI NI201800043A patent/NI201800043A/es unknown
- 2018-03-25 IL IL258341A patent/IL258341A/en unknown
- 2018-03-26 EC ECIEPI201823253A patent/ECSP18023253A/es unknown
- 2018-03-26 CL CL2018000783A patent/CL2018000783A1/es unknown
- 2018-03-27 DO DO2018000083A patent/DOP2018000083A/es unknown
- 2018-03-28 CO CONC2018/0003473A patent/CO2018003473A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018535931A (ja) | 2018-12-06 |
| CR20180181A (es) | 2018-06-22 |
| IL258341A (en) | 2018-05-31 |
| CU20180028A7 (es) | 2018-07-05 |
| US20180273528A1 (en) | 2018-09-27 |
| CN108137581A (zh) | 2018-06-08 |
| HK1255804A1 (zh) | 2019-08-23 |
| MX2018003860A (es) | 2018-08-16 |
| AU2016333505A1 (en) | 2018-04-19 |
| MA43020A (fr) | 2018-08-08 |
| EA201890821A1 (ru) | 2018-10-31 |
| FR3041639B1 (fr) | 2019-01-25 |
| KR20180054858A (ko) | 2018-05-24 |
| NI201800043A (es) | 2018-06-21 |
| PH12018500650A1 (en) | 2018-10-01 |
| BR112018006157A2 (pt) | 2018-10-09 |
| CA2999935A1 (en) | 2017-04-06 |
| FR3041639A1 (es) | 2017-03-31 |
| EP3356363A1 (en) | 2018-08-08 |
| CO2018003473A2 (es) | 2018-07-10 |
| TN2018000090A1 (en) | 2019-07-08 |
| ECSP18023253A (es) | 2018-04-30 |
| PE20181331A1 (es) | 2018-08-20 |
| DOP2018000083A (es) | 2018-10-15 |
| CL2018000783A1 (es) | 2018-09-21 |
| WO2017055530A1 (en) | 2017-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2018005722A (es) | Nuevos derivados de amonio, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| SV2018005656A (es) | Nuevos derivados de pirrolo[2,3-d]pirimidina,un proceso para su preparacion y composiciones farmaceuticas que los contiene | |
| SV2018005791A (es) | Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| CO7210068A1 (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| CR20170575A (es) | Nuevos derivados bicíclicos, un proceso para su preparación y composiciones farmacéuticas que los continen. | |
| SV2017005587A (es) | Nuevos derivados hidroxiester, un proceso para su preparacion y composiciones farmaceutacas que los contienen | |
| SV2017005514A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
| SV2017005590A (es) | Nuevos derivados hidroxiacido un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| SV2018005657A (es) | "nuevos derivados de imidazo[4,5-b]piridina, un proceso para su preparacion y composiciones farmaceuticas que los contienen" | |
| NI201400080A (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| NI201400079A (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| UY36733A (es) | Nuevos derivados aminoácido, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| MX2017009505A (es) | Derivados de 9h-pirrolo-dipiridina. | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| SV2014004879A (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen |